The CDPH's 2023 budget is set to shrink in the year ahead. Crain’s health care reporter Katherine Davis talks with host Amy Guth about why that matters.
In just three months, AbbVie’s leading product, Humira, will face biosimilar competition in the U.S. for the first time. Crain’s health care reporter Katherine Davis discusses with host Amy Guth.